Rajillah Omar, Piercecchi Antoine, Girardot Guillaume, Baulot Emmanuel, Lebaron Marie, Martz Pierre
Department of Orthopedic and Traumatological Surgery, Hôpital François Mitterrand, CHU, 21079 Dijon Cedex, France.
Department of Orthopedic and Traumatological Surgery, Hôpital François Mitterrand, CHU, 21079 Dijon Cedex, France.
Orthop Traumatol Surg Res. 2024 Oct 24:104031. doi: 10.1016/j.otsr.2024.104031.
Acetabular fractures account for 7% of osteoporotic fractures, with an epidemiological peak between 75 and 80 years of age. The aim of this study is to evaluate the results of treatment of these fractures in a population aged over 65.
Surgical treatment would lead to better survival and functional outcomes in the management of acetabular fractures in subjects aged over 65.
Patients over 65 years of age treated for acetabular fracture between January 2017 and May 2020 were included in this retrospective single-center study and divided into three treatment groups: osteosynthesis, osteosynthesis-THA (Osteosynthesis-THA) and orthopedic treatment. The choice of treatment was made according to an algorithm that considered the patient's co-morbidities, autonomy and bone lesions. The primary endpoint was patient survival at 12 and 24 months' follow-up.
94 patients (mean age 78.5 +/-8.4 years) were included: 29 patients treated with orthopedic therapy, 46 patients with osteosynthesis and 19 patients with osteosynthesis-THA. Mean follow-up was 32.7+/-14.9 months. Mortality rates were higher in the orthopedic and osteosynthesis-THA groups (20.7% and 21.1% respectively). Patients in the orthopedic and osteosynthesis-THA groups showed excess mortality, with hazard ratios (HR) of 3.4 ([1.02; 11.3], p < 0.05) and 3.3 ([0.9; 12.3], p = 0.08) respectively, compared with those treated with osteosynthesis. Mean PMA at 2 years, mean Harris score at 2 years and Parker score were significantly higher in the operated groups. The rate of conversion to THA (THA) was higher in the orthopedic treatment group (27.6%). The complication rate was 24% (11/46) for the osteosynthesis group, 42% (8/19) for the osteosynthesis-THA group.
Applying our decision algorithm, orthopedic treatment is inferior to surgical treatment in terms of survival and functional results, with a higher re-intervention rate for THA than treatment with osteosynthesis. This study confirms the place of osteosynthesis, with higher functional scores, lower complication and revision rates, and a positive effect on mortality.
IV; Retrospective cohort study.
髋臼骨折占骨质疏松性骨折的7%,发病高峰在75至80岁之间。本研究的目的是评估65岁以上人群中这些骨折的治疗结果。
手术治疗在65岁以上患者髋臼骨折的治疗中能带来更好的生存率和功能结果。
本回顾性单中心研究纳入了2017年1月至2020年5月间接受髋臼骨折治疗的65岁以上患者,并分为三个治疗组:接骨术、接骨术-全髋关节置换术(Osteosynthesis-THA)和矫形治疗。治疗方案根据考虑患者合并症、自主能力和骨损伤情况的算法来选择。主要终点是随访12个月和24个月时的患者生存率。
纳入94例患者(平均年龄78.5±8.4岁):29例接受矫形治疗,46例接受接骨术,19例接受接骨术-全髋关节置换术。平均随访时间为32.7±14.9个月。矫形治疗组和接骨术-全髋关节置换术组的死亡率较高(分别为20.7%和21.1%)。与接受接骨术治疗的患者相比,矫形治疗组和接骨术-全髋关节置换术组患者的死亡率过高,风险比(HR)分别为3.4([1.02;11.3],p<0.05)和3.3([0.9;12.3],p = 0.08)。手术组2年时的平均PMA、2年时的平均Harris评分和Parker评分显著更高。矫形治疗组转为全髋关节置换术(THA)的比例更高(27.6%)。接骨术组的并发症发生率为24%(11/46),接骨术-全髋关节置换术组为42%(8/19)。
应用我们的决策算法,矫形治疗在生存率和功能结果方面不如手术治疗,全髋关节置换术的再次干预率高于接骨术治疗。本研究证实了接骨术的地位,其功能评分更高,并发症和翻修率更低,且对死亡率有积极影响。
IV;回顾性队列研究。